The pharmaceuticals sector was under pressure today after high-profile setbacks for AstraZeneca and GlaxoSmithKline spooked investors.

Pharmaceuticals giant GlaxoSmithKline today raised its full-year earnings target after reporting a boost in sales despite setbacks in the launch of new drugs.